Clinical Trials Browser

OTHER × MLN2238 × Lymphoid × Clear all

NCT04047797 2025-04-20

Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Phase 2 Terminated

3 enrolled 10 charts

Lymphoma, Mantle-Cell